[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alpha Cognition Inc (ACOGF)

Alpha Cognition Inc (ACOGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 52,800
  • Shares Outstanding, K 150,856
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,770 K
  • EBIT $ -12 M
  • EBITDA $ -12 M
  • 60-Month Beta 2.80
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings $-0.01 on 08/12/24
  • Next Earnings Date 11/26/24
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate $-0.04
  • Number of Estimates 1
  • High Estimate $-0.04
  • Low Estimate $-0.04
  • Prior Year $-0.03
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3500 unch
on 11/04/24
0.5000 -30.00%
on 10/21/24
-0.0600 (-14.63%)
since 10/04/24
3-Month
0.3500 unch
on 11/04/24
0.5300 -33.96%
on 08/12/24
-0.1600 (-31.37%)
since 08/02/24
52-Week
0.1638 +113.68%
on 11/07/23
0.7398 -52.69%
on 01/19/24
+0.0766 (+28.02%)
since 11/03/23

Most Recent Stories

More News
Alpha Cognition Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.3500 (-7.89%)
Alpha Cognition Provides Private Placement Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“ Alpha Cognition ”, or the “ Company ”), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders,...

ACOG.VN : 0.240 (unch)
ACOGF : 0.3500 (-7.89%)
Alpha Cognition Announces Third Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.3500 (-7.89%)
Alpha Cognition Announces Second Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.3500 (-7.89%)
Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative...

ACOG.VN : 0.240 (unch)
ACOGF : 0.3500 (-7.89%)
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be...

NSCI.VN : 0.125 (+4.17%)
KPIFF : 0.0264 (+7.32%)
BRM.VN : 3.020 (-0.33%)
VIBEF : 0.3905 (-5.81%)
OGGFF : 0.0001 (unch)
NTE.VN : 0.060 (unch)
MRV.TO : 31.61 (-7.14%)
OAMCF : 0.1084 (+2.36%)
VHI.TO : 6.58 (+0.92%)
KUT.VN : 4.960 (+0.20%)
GBLT.VN : 0.005 (unch)
HS.CN : 0.5300 (unch)

Business Summary

Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.

See More

Key Turning Points

3rd Resistance Point 0.4275
2nd Resistance Point 0.4120
1st Resistance Point 0.3810
Last Price 0.3500
1st Support Level 0.3345
2nd Support Level 0.3190
3rd Support Level 0.2880

See More

52-Week High 0.7398
Fibonacci 61.8% 0.5198
Fibonacci 50% 0.4518
Fibonacci 38.2% 0.3838
Last Price 0.3500
52-Week Low 0.1638

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.